TL;DR
This study reveals that human tau protein, often associated with neurodegenerative diseases, plays a crucial role in regulating cellular metabolism during acute hyperglycemia. It promotes a Warburg effect-like metabolic shift towards glycolysis by influencing how proteins associate with cell membranes, which could be a protective mechanism against hyperglycemia-induced stress.
What Problem Does This Paper Address?
While hyperphosphorylated tau is a known hallmark of neurodegenerative diseases like Alzheimer's, its normal physiological functions, especially under conditions of metabolic stress, remain poorly understood. Specifically, how tau influences cellular metabolism, particularly during hyperglycemia, and its role in protein-membrane interactions in this context were unclear. This paper aims to elucidate these functions, focusing on the early stages of acute hyperglycemia.
Methods
The researchers employed a multi-pronged approach:
- Animal Models: They used three types of mice: human tau transgenic (hTau) mice, tau knockout (Tau KO) mice, and wild-type (C57BL/6J) mice. These models allowed them to investigate the effects of human tau in the absence of murine tau and in comparison to its complete absence.
- Hyperglycemia Induction: Acute hyperglycemia was induced in these mice using streptozotocin (STZ) injections.
- Biochemical Analysis: They performed Western blotting to measure protein levels and phosphorylation states of key signaling molecules (e.g., Akt, GSK-3β, JNK, mTOR).
- Proteomics: TMT-labeled quantitative proteomics was used to analyze the membrane-associated proteome in the hippocampus to understand how tau affects protein localization and interactions.
- Cell Culture Studies: Human tau-overexpressing HEK293 cells (293tau) and normal HEK293 cells were used for in vitro experiments.
- Metabolic Assays: Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were measured using Seahorse analyzers to assess glycolysis and oxidative phosphorylation.
- Biochemical Assays: Levels of pyruvate, lactate, NAD+, ROS, and SDH activity were measured.
- Inhibitor Studies: Specific inhibitors for JNK and mTOR pathways were used to dissect the signaling mechanisms.
Datasets
Not explicitly detailed as separate datasets, but the study utilized data generated from:
- Mouse models (hTau, Tau KO, C57BL/6J, 3xTg AD mice).
- HEK293 cell lines (normal and tau-overexpressing).
- Hippocampal and cortical tissue samples from these mice.
Key Insights and Ideas
- JNK, Not GSK-3β, Drives Tau Phosphorylation in Acute Hyperglycemia: Contrary to previous findings in chronic hyperglycemia models, acute hyperglycemia primarily activates JNK, not GSK-3β, to phosphorylate tau. This suggests different signaling pathways are involved depending on the duration of the metabolic stress.
- Tau Modulates Protein-Membrane Association: Human tau significantly alters the composition of membrane-associated proteins. It strengthens the association of proteins involved in glycolysis and mitochondrial function (like TFAM, TRAP1, mTOR) while weakening others, such as those involved in oxidative phosphorylation, ribosome, and proteasome function.
- Tau Promotes a Warburg Effect-like Metabolism: In the presence of high glucose, tau promotes aerobic glycolysis (Warburg effect), which helps maintain the NAD+/NADH ratio. This is achieved by influencing membrane protein organization.
- Tau Restricts Oxidative Phosphorylation and ROS Production: While promoting glycolysis, tau simultaneously limits oxidative phosphorylation and reduces reactive oxygen species (ROS) production under high glucose stress. This could be a protective mechanism.
- Tau Regulates mTORC2 Activation: Tau appears to promote an alternative activation of mTORC2, which in turn influences Akt activation, contributing to the metabolic reprogramming.
Key Results
- Metabolic Shift: Under acute hyperglycemia, hTau mice showed increased aerobic glycolysis and maintained NAD+/NADH ratios, characteristic of the Warburg effect.
- Protein Localization Changes: Proteomic analysis revealed significant alterations in membrane-associated proteins in hTau mice, with key proteins like TFAM and mTOR showing increased association.
- Reduced Oxidative Phosphorylation: OCR measurements showed lower basal and maximal respiration, as well as reduced ATP production, in tau-expressing cells under high glucose.
- ROS Reduction: High glucose-induced ROS production was attenuated in tau-expressing cells.
- SDH Activity: The activity of succinate dehydrogenase (SDH), a key enzyme in the electron transport chain, was significantly higher in tau-expressing cells, potentially contributing to increased coupling efficiency.
Limitations and Future Work
- Time Course Differences: The study highlights that the observed effects of tau phosphorylation differ based on the duration of hyperglycemia, suggesting that further investigation into chronic hyperglycemia effects is warranted.
- Mechanism of mTORC2 Activation: While tau's role in alternative mTORC2 activation is suggested, the detailed underlying mechanisms require further study.
- Tau Aggregation: The paper notes that tau aggregation, as seen in AD, may lead to its dysfunction in regulating metabolism. Future work could explore how tau aggregation impacts these metabolic effects.
- Therapeutic Potential: The findings suggest that tau's role in metabolic regulation could be a target for therapeutic interventions in conditions involving hyperglycemia and neurodegeneration. Further research could explore how modulating tau's interaction with membrane proteins or its signaling pathways might offer benefits.
Summary updated